Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat

Edward R O'Brien1, Jagdeep K Sandhu2

  • 1Division of Cardiology, Department of Cardiac Sciences, University of Calgary Cumming School of Medicine, Libin Cardiovascular Institute, HRIC GC68, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada. ermobrie@ucalgary.ca.

Abstract

No abstract available in PubMed .